| Target Price | $634.95 |
| Price | $572.41 |
| Potential |
10.93%
register free of charge
|
| Number of Estimates | 26 |
|
26 Analysts have issued a price target Thermo Fisher Scientific 2026 .
The average Thermo Fisher Scientific target price is $634.95.
This is
10.93%
register free of charge
$708.75
23.82%
register free of charge
$538.49
5.93%
register free of charge
|
|
| A rating was issued by 32 analysts: 25 Analysts recommend Thermo Fisher Scientific to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Thermo Fisher Scientific stock has an average upside potential 2026 of
10.93%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 42.88 | 44.71 |
| 0.05% | 4.28% | |
| EBITDA Margin | 25.24% | 24.80% |
| 0.88% | 1.76% | |
| Net Margin | 14.77% | 19.39% |
| 5.62% | 31.24% |
28 Analysts have issued a sales forecast Thermo Fisher Scientific 2025 . The average Thermo Fisher Scientific sales estimate is
This results in the following potential growth metrics:
27 Analysts have issued an Thermo Fisher Scientific EBITDA forecast 2025. The average Thermo Fisher Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Thermo Fisher Scientific Analysts have issued a net profit forecast 2025. The average Thermo Fisher Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 16.54 | 22.96 |
| 7.06% | 38.81% | |
| P/E | 24.65 | |
| EV/Sales | 5.47 |
30 Analysts have issued a Thermo Fisher Scientific forecast for earnings per share. The average Thermo Fisher Scientific EPS is
This results in the following potential growth metrics and future valuations:
Thermo Fisher Scientific...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Argus Research:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Oct 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


